Metabotropic glutamate receptors in GtoPdb v.2021.3 by Acher, Francine et al.
IUPHAR/BPS	Guide	to	Pharmacology	CITE
https://doi.org/10.2218/gtopdb/F40/2021.3
Metabotropic	glutamate	receptors	in	GtoPdb	v.2021.3
Francine	Acher1,	Giuseppe	Battaglia2,	Hans	Bräuner-Osborne3,	P.	Jeffrey	Conn4,	Robert	Duvoisin5,
Francesco	Ferraguti6,	Peter	J.	Flor7,	Cyril	Goudet8,	Karen	J.	Gregory9,	David	Hampson10,	Michael	P.
Johnson11,	Yoshihiro	Kubo12,	James	Monn13,	Shigetada	Nakanishi14,	Ferdinando	Nicoletti15,	Colleen
Niswender4,	Jean-Philippe	Pin8,	Philippe	Rondard8,	Darryle	D.	Schoepp11,	Ryuichi	Shigemoto16	and
Michihiro	Tateyama12
1.	 Université	René	Descarte,	France
2.	 IRCCS	NEUROMED,	Italy
3.	 University	of	Copenhagen,	Denmark
4.	 Vanderbilt	University,	USA
5.	 Oregon	Health	&	Science	University,	USA
6.	 Innsbruck	University,	Austria
7.	 Novartis	Institutes	for	Biomedical	Research,	Switzerland
8.	 Université	de	Montpellier,	France
9.	 Monash	University,	Australia
10.	 University	of	Toronto,	Canada
11.	 Lilly	Research	Laboratories,	USA
12.	 National	Institute	for	Physiological	Sciences,	Japan
13.	 Eli	Lilly	and	Company,	USA
14.	 Kyoto	University	Faculty	of	Medicine,	Japan
15.	 University	of	Rome	'La	Sapienza',	Italy
16.	 Institute	of	Science	and	Technology,	Austria
Abstract
Metabotropic	glutamate	(mGlu)	receptors	(nomenclature	as	agreed	by	the	NC-IUPHAR
Subcommittee	on	Metabotropic	Glutamate	Receptors	[347])	are	a	family	of	G	protein-coupled
receptors	activated	by	the	neurotransmitter	glutamate	[138].	The	mGlu	family	is	composed	of	eight
members	(named	mGlu1	to	mGlu8)	which	are	divided	in	three	groups	based	on	similarities	of	agonist
pharmacology,	primary	sequence	and	G	protein	coupling	to	effector:	Group-I	(mGlu1	and	mGlu5),
Group-II	(mGlu2	and	mGlu3)	and	Group-III	(mGlu4,	mGlu6,	mGlu7	and	mGlu8)	(see	Further	reading).
Structurally,	mGlu	are	composed	of	three	juxtaposed	domains:	a	core	G	protein-activating	seven-
transmembrane	domain	(TM),	common	to	all	GPCRs,	is	linked	via	a	rigid	cysteine-rich	domain	(CRD)
to	the	Venus	Flytrap	domain	(VFTD),	a	large	bi-lobed	extracellular	domain	where	glutamate	binds.
mGlu	form	constitutive	dimers,	cross-linked	by	a	disulfide	bridge.	The	structures	of	the	VFTD	of
mGlu1,	mGlu2,	mGlu3,	mGlu5	and	mGlu7	have	been	solved	[198,	271,	264,	399].	The	structure	of	the
7	transmembrane	(TM)	domains	of	both	mGlu1	and	mGlu5	have	been	solved,	and	confirm	a	general
helical	organization	similar	to	that	of	other	GPCRs,	although	the	helices	appear	more	compacted	[87,
429,	61].	Recent	advances	in	cryo-electron	microscopy	have	provided	structures	of	full-length	mGlu
receptor	dimers	[189].	Studies	have	revealed	the	possible	formation	of	heterodimers	between	either
group-I	receptors,	or	within	and	between	group-II	and	-III	receptors	[88].	First	well	characterized	in
transfected	cells,	co-localization	and	specific	pharmacological	properties	also	suggest	the	existence
of	such	heterodimers	in	the	brain	[266].[436,	143,	279].	Beyond	heteromerization	with	other	mGlu
receptor	subtypes,	increasing	evidence	suggests	mGlu	receptors	form	heteromers	and	larger	order
complexes	with	class	A	GPCRs	(reviewed	in	[138]).	
The	endogenous	ligands	of	mGlu	are	L-glutamic	acid,	L-serine-O-phosphate,	N-
acetylaspartylglutamate	(NAAG)	and	L-cysteine	sulphinic	acid.	Group-I	mGlu	receptors	may	be
activated	by	3,5-DHPG	and	(S)-3HPG	[30]	and	antagonized	by	(S)-hexylhomoibotenic	acid	[232].
Group-II	mGlu	receptors	may	be	activated	by	LY389795	[265],	LY379268	[265],	eglumegad	[350,
430],	DCG-IV	and	(2R,3R)-APDC	[351],	and	antagonised	by	eGlu	[168]	and	LY307452	[421,	103].
Group-III	mGlu	receptors	may	be	activated	by	L-AP4	and	(R,S)-4-PPG	[128].	An	example	of	an
antagonist	selective	for	mGlu	receptors	is	LY341495,	which	blocks	mGlu2	and	mGlu3	at	low
nanomolar	concentrations,	mGlu8	at	high	nanomolar	concentrations,	and	mGlu4,	mGlu5,	and	mGlu7
in	the	micromolar	range	[183].	In	addition	to	orthosteric	ligands	that	directly	interact	with	the
glutamate	recognition	site,	allosteric	modulators	that	bind	within	the	TM	domain	have	been
described.	Negative	allosteric	modulators	are	listed	separately.	The	positive	allosteric	modulators
most	often	act	as	‘potentiators’	of	an	orthosteric	agonist	response,	without	significantly	activating
the	receptor	in	the	absence	of	agonist.
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